Filed with the SEC as Titterton Lewis H jr; the order above is the one the filer's own signature uses.
In the 12 months to Nov 8, 2026, on the open market: bought $241K of ANIX. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $241KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
ANIXBought: Anixa Biosciences Inc Oct 23, 20268,000 sharesfiled Oct 26, 20261,054,003 shares held directly after, as filedfiling$24K
ANIXBought: Anixa Biosciences Inc Sep 23, 202649,036 sharesfiled Sep 25, 20261,046,003 shares held directly after, as filedfiling$132K
ANIXBought: Anixa Biosciences Inc Sep 10, 202610,000 sharesfiled Sep 14, 2026996,967 shares held directly after, as filedfiling$27K
ANIXBought: Anixa Biosciences Inc Jul 20, 202612,000 sharesfiled Jul 20, 2026986,967 shares held directly after, as filedfiling$42K
ANIXBought: Anixa Biosciences Inc Jul 15, 20262,797 sharesfiled Jul 16, 2026974,967 shares held directly after, as filedfiling$9K
ANIXBought: Anixa Biosciences Inc Jun 16, 20262,836 sharesfiled Jun 17, 2026972,170 shares held directly after, as filedfiling$7K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.